CHARMAINE LUVIS: Open Payments
NPI 1134385776 · GASTONIA, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,198 in 85 payments from 12 companies in 2025. Trend: 2023 $1,034 · 2024 $1,091 · 2025 $1,198
Food & beverage: $1,198
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $419 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $172 |
| Otsuka America Pharmaceutical, Inc. | 5 | $121 |
| PFIZER INC. | 5 | $99 |
| Phathom Pharmaceuticals, Inc. | 9 | $95 |
| Lilly USA, LLC | 4 | $79 |
| Corcept Therapeutics | 4 | $66 |
| Novo Nordisk Inc | 3 | $59 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
Products named: VRAYLAR, CAPLYTA, REXULTI, VOQUEZNA, MOUNJARO, Korlym, PREVNAR 20, TRELEGY ELLIPTA.
Industry payments across NC — which companies pay providers there.
